Skip to main content
. Author manuscript; available in PMC: 2019 May 15.
Published in final edited form as: Clin Cancer Res. 2018 May 29;24(22):5724–5734. doi: 10.1158/1078-0432.CCR-17-3364

Figure 4. Detection of gastric adenocarcinoma (GAC) by assay of novel methylated DNA marker candidates in plasma.

Figure 4

(A) Area under the reciever operating characteristic curves (AUCs) for three selected markers alone and in a combined panel. (B) Quantiation of methylated ELMO1 levels across GAC tumor stages. (C) Marker panel sensitivites at 100% specificity across tumor stages.